tirzepatide surmount 5 In an earlier analysis of the SURMOUNT-1 trial, (a dual glucose-dependent insulinotropic polypeptide [GIP] and glucagon-like peptide-1 [GLP-1] receptor agonist) was shown to provide substantial and sustained reductions in body weight SURMOUNT-5: Tirzepatide and semaglutide go

Of note, genes involved in the same processes (aerobic glycolysis, translation of mitochondrial proteins, heat shock response) are upregulated by the mitochondrial unfolded protein response (UPR mt ) in the nematode Caenorhabditis elegans and the yeast Saccharomyces cerevisiae [36, 37], indicating that this phenomenon could also occur in our model

This mechanism makes it a mechanical blocker rather than a hormonal modifier, targeting fat intake rather than appetite regulation

These benefits persist through year five and appear to strengthen with continued medication adherence, independent of weight loss alone

It affects glucogenesis in the ovaries by lowering it, which leads to a reduction in androgen synthesis in the ovaries (138)